Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04857424 · ClinicalTrials.gov registry record

Quality of Life Assessment Between Internal Endoscopic Versus Percutaneous Drainage in Biliary Obstruction

A clinical trial of Biliary Obstruction, sponsored by Mayo Clinic.

Active
Registry status
206
Enrollment target
1
Study location

NCT04857424 is a study of Biliary Obstruction that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 206 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04857424, a study of Biliary Obstruction, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
206 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to compare the quality of life in subjects with benign and malignant biliary obstruction who have or will undergo endoscopic retrograde cholangiopancreatography (ERCP) and/or percutaneous trans-hepatic biliary drainage (PTBD).

Conditions Studied

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 206 participants
Start Date 2021-07-15
Est. Completion 2026-03-31

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04857424

The ClinicalTrials.gov registry entry for NCT04857424 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Biliary Obstruction appearing as the primary indexed condition, and to 0 interventions.

NCT04857424 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04857424 about?

NCT04857424 is a clinical study titled "Quality of Life Assessment Between Internal Endoscopic Versus Percutaneous Drainage in Biliary Obstruction". The aim of this study is to compare the quality of life in subjects with benign and malignant biliary obstruction who have or will undergo endoscopic retrograde cholangiopancreatography (ERCP) and/or percutaneous trans-hepatic biliary drainage (PTBD).

What is the current status of trial NCT04857424?

This trial is currently active not recruiting. The enrollment target is 206 participants. The study started on 2021-07-15. Estimated completion is 2026-03-31.

What conditions does trial NCT04857424 study?

This clinical trial studies the following conditions: Biliary Obstruction.

Who is sponsoring clinical trial NCT04857424?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04857424 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Biliary Obstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.